# FDA 483 - Jay E. Gladstein, MD - July 12, 2019

Source: https://www.globalkeysolutions.net/records/483/jay-e-gladstein-md/9f64f9c6-ed15-41c2-a4d5-4a2c5d9dc8df

> FDA 483 for Jay E. Gladstein, MD on July 12, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Jay E. Gladstein, MD
- Inspection Date: 2019-07-12
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Jay E. Gladstein, MD in Los Angeles, CA, identified a significant issue regarding adherence to the investigational plan. The firm failed to conduct an investigation in accordance with its plan, specifically concerning dispensing errors where three study subjects received incorrect study drugs. Two of these subjects subsequently dosed with the wrong medication, posing a potential risk to their safety.

## Related Officers

- [Grandfather, Fisherman, and loving life!](https://www.globalkeysolutions.net/people/mark-babbitt/c093bebb-75e1-4b20-a8d5-72c4e1d81c6d)

Company: https://www.globalkeysolutions.net/companies/jay-e-gladstein-md/56e9910e-404a-48ea-aa07-5b259f58a094

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6